China Risun Group announced that its subsidiary, Dongming Risun Chemical Co., Ltd., has been officially approved by the Shandong Provincial Department of Human Resources and Social Security to establish a Postdoctoral Innovation Practice Base.
This recognition strengthens China Risun’s position as a leader in talent development and technological innovation. With the addition of Dongming Risun, the Group now operates seven postdoctoral innovation practice bases across China, further enhancing its nationwide R&D ecosystem.
Driving Innovation Through Talent
The Postdoctoral Innovation Practice Base is a national initiative designed to attract and cultivate high-level talent, accelerate the transformation of scientific achievements into industrial applications, and deepen collaboration between industry, academia, and research. Dongming Risun’s approval reflects both the company’s strong innovation capacity and China Risun’s long-term commitment to building a world-class talent pipeline.
Dongming Risun employs over 950 staff, including 4 PhDs and 25 Master’s degree holders. Located in Shandong’s Dongming Engineering Plastics Industrial Park, the company operates a fully integrated industrial chain from benzene to nylon 6 polymer chips. With RMB 2.23 billion in registered capital and advanced production facilities, Dongming Risun has secured 35 national patents and developed 9 proprietary technologies, laying a solid foundation for high-quality, innovation-driven growth.
Global Leadership in Chemicals and Energy
China Risun Group is recognized as:
The world’s largest independent coke producer and supplier
The world’s largest processor of crude benzene from coking
The world’s second-largest caprolactam producer
China’s largest industrial naphthalene-based phthalic anhydride producer
China’s largest coke oven gas-to-methanol producer
China’s second-largest supplier of high-purity hydrogen
Ranked among China’s Top 500 Enterprises and Top 50 Chemical Enterprises, China Risun has built a three-tier R&D system spanning group, park, and company levels. The Group operates more than 20 research institutes, a thousand-member R&D team led by 120+ PhDs, and extensive laboratory and pilot testing facilities. To date, China Risun has achieved 585 proprietary technologies, 626 patents, and 194 software copyrights, driving breakthroughs in new energy, new materials, fine chemicals, and digital industries.
Deep Industry–Education Integration
China Risun has forged partnerships with 49 universities, including 11 top-tier “985” and “211” institutions, to advance talent cultivation and collaborative research. Initiatives include joint colleges, targeted training programs, degree enhancement classes, overseas employee training, and postdoctoral cooperation projects. These collaborations have delivered significant results in environmental protection, fine chemicals, new materials, and energy innovation, earning multiple provincial and national awards.
Commitment to Excellence
China Risun and Dongming Risun will leverage the Group’s mature experience in operating six existing bases to ensure high-standard facilities, robust operating systems, and comprehensive support for postdoctoral researchers. This includes funding, project initiation, R&D implementation, career advancement, and housing support — ensuring that talent can be effectively attracted, retained, and empowered.
“The establishment of Dongming Risun’s Postdoctoral Innovation Practice Base marks another milestone in China Risun’s innovation journey,” said a company spokesperson. “We are confident this platform will generate valuable technological breakthroughs, nurture top-tier talent, and contribute to regional economic growth and the Group’s global vision.”
